Biomarin Pharmaceutical Inc (BMRN)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 426,859 | 167,645 | 141,561 | -64,080 | 854,029 |
| Revenue | US$ in thousands | 2,845,320 | 2,374,190 | 2,068,670 | 1,832,750 | 1,823,140 |
| Net profit margin | 15.00% | 7.06% | 6.84% | -3.50% | 46.84% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $426,859K ÷ $2,845,320K
= 15.00%
Biomarin Pharmaceutical Inc's net profit margin has shown significant fluctuations over the years based on the provided data. In December 2020, the net profit margin was robust at 46.84%, indicating that the company was efficient in converting revenue into profit. However, by December 2021, the net profit margin had turned negative, reaching -3.50%, reflecting that the company's costs and expenses exceeded its total revenue.
In the following years, Biomarin Pharmaceutical Inc managed to improve its profitability as evidenced by the net profit margin increasing to 6.84% in December 2022 and further to 7.06% in December 2023. These improvements suggest that the company made efforts to control costs and enhance operational efficiency.
By December 2024, Biomarin Pharmaceutical Inc's net profit margin had surged to 15.00%, indicating a strong performance in converting revenue into profit. This substantial increase in profitability could be attributed to various factors such as revenue growth, cost management strategies, or operational optimizations.
Overall, Biomarin Pharmaceutical Inc's net profit margin has experienced fluctuations but has shown a positive trend in recent years, demonstrating the company's ability to enhance profitability and financial performance.
Peer comparison
Dec 31, 2024